Skip to main content

Olerup, Conexio Ink Deal for HLA Sequencing Products, Software

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –Transplantation molecular diagnostics firm Olerup today announced a deal to market, sell, and distribute Conexio's HLA sequencing products and software.

The agreement covers Conexio's SBT Resolver products, which are locus-specific PCR-based HLA sequencing-based typing reagents. Included in the deal are SBT kits and a version of the Assign sequence analysis software. Olerup and its sub-distributors will sell Conexio's products.

The firms also will co-develop new HLA typing products.

Financial and other terms of the deal were not disclosed.

Olle Olerup, CEO of Olerup, said in a statement that the agreement with Conexio will broaden and strengthen his company's position in the HLA space "with a very competitive SBT solution that complements our current product portfolio."

Based in Stockholm, Olerup is a LinkMed firm and distributes molecular diagnostic products and services for HLA typing and antibody detection. Conexio is based in Fremantle, Australia and develops sequencing technology for HLA typing and mutation detection.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.